Home > Insider Trading > Filing (0001209191-14-067053)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1142596	Nuvasive Inc	NUVA	Surgical & Medical Instruments & Apparatus (3841)	330768598

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1289409	Patrick Miles	7475 Lusk Blvd. San Diego CA 92121	President, Global Prod & Svcs	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-11-04	15,413	$18.31	62,914	No	4	M	Direct
Common Stock	Disposition	2014-11-04	15,413	$41.24	47,501	No	4	S	Direct
Common Stock	Acquisiton	2014-11-04	5,564	$23.24	53,065	No	4	M	Direct
Common Stock	Disposition	2014-11-04	5,564	$41.24	47,501	No	4	S	Direct
Common Stock	Acquisiton	2014-11-04	8,767	$23.24	56,268	No	4	M	Direct
Common Stock	Disposition	2014-11-04	8,767	$41.24	47,501	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2006-01-03	15,413	$0.00	15,413	$18.31
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2007-01-16	5,564	$0.00	5,564	$23.24
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2007-01-16	8,767	$0.00	8,767	$23.24

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2016-01-03	No	4	M	Direct
2017-01-16	No	4	M	Direct
2017-01-16	No	4	M	Direct

Footnotes

Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
Weighted average from 235 transactions with prices ranging from $41.10 to $41.55. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
The option, representing a right to purchase a total of 39,061 shares, became exercisable as follows: 25% of the shares vested on January 3, 2007; 1/48th of the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2010, subject to continued employment through each vesting period.
The option, representing a right to purchase a total of 5,564 shares, became exercisable as follows: 25% of the shares vested on January 16, 2008; 1/48th of the remaining shares vested monthly thereafter so that all shares were fully vested as of January 16, 2011, subject to continued employment through each vesting period.
The option, representing a right to purchase a total of 94,436 shares, became exercisable as follows: 25% of the shares vested on January 16, 2008; 1/48th of the remaining shares vested monthly thereafter so that all shares were fully vested as of January 16, 2011, subject to continued employment through each vesting period.